Cue Biopharma Inc.

NASDAQ: CUE · Real-Time Price · USD
0.82
0.03 (3.80%)
At close: Aug 15, 2025, 9:55 AM
3.80%
Bid 0.82
Market Cap 63.01M
Revenue (ttm) 7.99M
Net Income (ttm) -40.58M
EPS (ttm) -0.51
PE Ratio (ttm) -1.61
Forward PE -1.48
Analyst Buy
Ask 0.84
Volume 35,846
Avg. Volume (20D) 322,696
Open 0.81
Previous Close 0.79
Day's Range 0.79 - 0.83
52-Week Range 0.45 - 1.99
Beta 1.53

About CUE

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CUE
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Cue Biopharma has released their quartely earnings on Aug 12, 2025:
  • Revenue of $2.95M exceeds estimates by $954K, with 11.14% YoY growth.
  • EPS of -0.09 exceeds estimates by 0.04, with 55.00% YoY growth.
  • Next Earnings Release

    Cue Biopharma Inc. is scheduled to release its earnings on Nov 13, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -1.45%
    Cue Biopharma shares are trading higher after the ... Unlock content with Pro Subscription
    1 month ago
    +8.67%
    Cue Biopharma shares are trading higher after the company announced it received FDA pre-IND feedback for CUE-401 autoimmune therapy.